Literature DB >> 18279244

Potency of delta 9-THC and other cannabinoids in cannabis in England in 2005: implications for psychoactivity and pharmacology.

David J Potter1, Peter Clark, Marc B Brown.   

Abstract

Gas chromatography was used to study the cannabinoid content ("potency") of illicit cannabis seized by police in England in 2004/5. Of the four hundred and fifty two samples, indoor-grown unpollinated female cannabis ("sinsemilla") was the most frequent form, followed by resin (hashish) and imported outdoor-grown herbal cannabis (marijuana). The content of the psychoactive cannabinoid delta 9-tetrahydrocannabinol (THC) varied widely. The median THC content of herbal cannabis and resin was 2.1% and 3.5%, respectively. The median 13.9% THC content of sinsemilla was significantly higher than that recorded in the UK in 1996/8. In sinsemilla and imported herbal cannabis, the content of the antipsychotic cannabinoid cannabidiol (CBD) was extremely low. In resin, however, the average CBD content exceeded that of THC, and the relative proportions of the two cannabinoids varied widely between samples. The increases in average THC content and relative popularity of sinsemilla cannabis, combined with the absence of the anti-psychotic cannabinoid CBD, suggest that the current trends in cannabis use pose an increasing risk to those users susceptible to the harmful psychological effects associated with high doses of THC.

Entities:  

Year:  2008        PMID: 18279244     DOI: 10.1111/j.1556-4029.2007.00603.x

Source DB:  PubMed          Journal:  J Forensic Sci        ISSN: 0022-1198            Impact factor:   1.832


  53 in total

1.  Heterogeneity in the composition of marijuana seized in California.

Authors:  James Richard Burgdorf; Beau Kilmer; Rosalie Liccardo Pacula
Journal:  Drug Alcohol Depend       Date:  2011-02-01       Impact factor: 4.492

2.  Cannabis, a complex plant: different compounds and different effects on individuals.

Authors:  Zerrin Atakan
Journal:  Ther Adv Psychopharmacol       Date:  2012-12

3.  Cannabichromene is a cannabinoid CB2 receptor agonist.

Authors:  Michael Udoh; Marina Santiago; Steven Devenish; Iain S McGregor; Mark Connor
Journal:  Br J Pharmacol       Date:  2019-11-21       Impact factor: 8.739

4.  Cannabis and Cannabinoid Biology in Stroke.

Authors:  Sang-Ho Choi; Yongshan Mou; Afonso C Silva
Journal:  Stroke       Date:  2019-08-01       Impact factor: 7.914

Review 5.  Cannabis use in pregnancy and early life and its consequences: animal models.

Authors:  Miriam Schneider
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-07-02       Impact factor: 5.270

Review 6.  Marijuana Legalization: Impact on Physicians and Public Health.

Authors:  Samuel T Wilkinson; Stephanie Yarnell; Rajiv Radhakrishnan; Samuel A Ball; Deepak Cyril D'Souza
Journal:  Annu Rev Med       Date:  2015-10-19       Impact factor: 13.739

7.  Effect of combined doses of Δ(9)-tetrahydrocannabinol (THC) and cannabidiolic acid (CBDA) on acute and anticipatory nausea using rat (Sprague- Dawley) models of conditioned gaping.

Authors:  Erin M Rock; Cheryl L Limebeer; Linda A Parker
Journal:  Psychopharmacology (Berl)       Date:  2015-09-18       Impact factor: 4.530

8.  Challenges in quantifying marijuana use.

Authors:  Kevin M Gray; Noreen L Watson; Douglas K Christie
Journal:  Am J Addict       Date:  2009 Mar-Apr

9.  Effect of low doses of cannabidiolic acid and ondansetron on LiCl-induced conditioned gaping (a model of nausea-induced behaviour) in rats.

Authors:  E M Rock; L A Parker
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

10.  High-potency cannabis and the risk of psychosis.

Authors:  Marta Di Forti; Craig Morgan; Paola Dazzan; Carmine Pariante; Valeria Mondelli; Tiago Reis Marques; Rowena Handley; Sonija Luzi; Manuela Russo; Alessandra Paparelli; Alexander Butt; Simona A Stilo; Ben Wiffen; John Powell; Robin M Murray
Journal:  Br J Psychiatry       Date:  2009-12       Impact factor: 9.319

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.